Combination inhibitor BMS-986197 demonstrates good activity against HIV in early study
Maraviroc may work as PrEP in combination with another drug – but probably not by itself
Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption
Dolutegravir safe and highly effective in older children
TAF/emtricitabine maintains viral suppression as well as TDF regimens with less bone and kidney toxicity
Dose-finding trials of antibody-based drugs for HIV prevention will start soon
Long-acting injectable cabotegravir + rilpivirine works well as HIV maintenance therapy